welcome
Dyadic Netherlands is a subsidiary of Dyadic International Inc. with headquarters in Jupiter, Florida, USA. Dyadic International has manufactured and sold enzymes for the textiles, animal feed, starch, and food industries since 1994. Dyadic's global market reach and manufacturing capabilities enable it to market and sell enzymes to customers in more than 35 countries.
Dyadic Netherlands represents the R&D department of Dyadic International. Its facilities are located in Wageningen, The Netherlands. Amongst others the company develops strains of the fungus Chrysosporium lucknowense – or C1 – to rapidly discover and express genes and to manufacture the enzymes encoded by those genes, using C1 as the host organism. Read more
Check our website and/or contact us to find out what we have to offer.
news
Dyadic International Signs Term Sheet for Potential Exclusive Outlicense of C1 Technology for Biopharmaceutical Applications
JUPITER, Fla., June 9th, Dyadic International announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development. Under the terms of the proposed licensing transaction outlined in the term sheet, Dyadic is eligible to receive a substantial equity stake in EnGen Bio which will be led by Mark R. Alfenito, Ph.D.
